A woman who experiences little to no pain or anxiety has a mutation in a previously unknown gene that results in a build up of anandamide, an enzyme that “works
The Medical Cannabis Clinicians’ Society (MCCS) and the All-Party Parliamentary Group (APPG) for Medical Cannabis under Prescription issued new guidance last week identifying conditions for which there are “conclusive or
Not enough cannabis prescriptions for NHS England to publish Figures on NHS England prescriptions for medical cannabis are unlikely to be published by the end of March 2019, despite ministerial
By Barnaby De Hoedt A legal cannabis industry in Africa could be worth more than $7.1bn a year by 2023 if legislation is introduced in a number of the continent’s
A study claiming to link high-potency cannabis to psychosis was based on guessing the strength of the THC based on the name of the strain they had used. (Don’t laugh!)
On 15 March, the Global Partnership on Drug Policies and Development (GPDPD) published International Guidelines on Human Rights and Drug Policy. The document was produced alongside The International Centre on
Dame Sally Davies, England’s Chief Medical Officer, yesterday made the outrageous claim that “we know [THC] has an impact on the brain and causes depression, schizophrenia [and] brain development problems
The mother of 10-month-old Nathaniel Leahy has said that Epidiolex has had “some positive effects” on epilepsy but that full extract cannabis oil – which he is being denied –
New York Mayor Bill de Blasio threw his support behind cannabis legalisation at the end of 2018, saying that it should be accompanied by the expungement of 700,000 New Yorkers
Following United Nations (UN) agencies’ decision to adopt common drug policy that endorses decriminalisation of possession and use, the UN System Coordination Task Team has released a new report that
